Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a ...

(Reuters) - A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the ...

Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today ...

Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...

The study showed that medicine used to help asthma patients for more than 20 years could lessen or prevent acute allergic ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section on Artivabio.com. A webcast replay will be made available following the ...

The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...